Explore the words cloud of the 4-IN THE LUNG RUN project. It provides you a very rough idea of what is the project "4-IN THE LUNG RUN" about.
The following table provides information about the project.
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
|Coordinator Country||Netherlands [NL]|
|Total cost||7˙999˙948 €|
|EC max contribution||7˙999˙948 € (100%)|
1. H2020-EU.3.1.2. (Preventing disease)
|Duration (year-month-day)||from 2020-01-01 to 2024-12-31|
Take a look of project's partnership.
|1||ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM||NL (ROTTERDAM)||coordinator||1˙926˙250.00|
|2||INSTITUTE FOR DIAGNOSTIC ACCURACY RESEARCH BV||NL (GRONINGEN)||participant||1˙901˙500.00|
|3||FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI||IT (Milan)||participant||1˙398˙500.00|
|4||DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG||DE (HEIDELBERG)||participant||677˙443.00|
|5||THE UNIVERSITY OF NOTTINGHAM||UK (NOTTINGHAM)||participant||591˙240.00|
|6||INSTITUT CATALA D'ONCOLOGIA||ES (L'HOSPITALET DEL LLOBREGAT)||participant||526˙575.00|
|7||INSTITUT GUSTAVE ROUSSY||FR (VILLEJUIF)||participant||425˙750.00|
|8||UNIVERSITAETSKLINIKUM ESSEN||DE (ESSEN)||participant||368˙470.00|
|9||UNIVERSITY COLLEGE LONDON||UK (LONDON)||participant||184˙220.00|
With 338,000 EU-deaths annually, lung cancer is a devastating problem. CT screening has the potential to prevent ten-thousands of lung cancer deaths annually. The positive results of the Dutch-Belgian screening trial (NELSON), with relatively low referral rates, and the NLST in the USA provided conclusive evidence. However, implementation is likely to be limited, slow and of variable quality throughout Europe, and current guidelines could easily require up to 25 million CT screens annually. The most optimal strategy in risk-based lung-thoracic screening is still unknown regarding the optimal and most cost-effective (e.g., targeted) strategy 1) to recruit, 2) to integrate smoking cessation and co-morbidity-reducing services, and 3) to determine the (risk-based) screening interval. Personalised regimens based on the baseline CT result can potentially retain 85% of the mortality reduction achievable through screening at 45% less screens, thus potentially saving much unnecessary harm associated with screening, and 0.5-1 billion Euros per year. The heart of 4-IN-THE-LUNG-RUN is a randomised controlled trial amongst 24,000 individuals evaluating whether it is safe to have risk-based less intensive screening intervals after a negative baseline CT. Various methods to improve participation of hard-to-reach individuals will be assessed in five different healthcare settings. Innovative co-morbidity reducing strategies will be tested including other markers on CT imaging, as Calcium Score and COPD. Cost impact and cost-effectiveness analyses using a natural history model will steer implementation. The experienced consortium will strongly interact with key stakeholders, and discuss interim results with key other international initiatives on CT screening, biomarkers, and smoking cessation practices. This proposal will form the evidence base for risk-based lung cancer screening with huge benefits for the EU, on health outcomes, cost savings, and innovation in the long run.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "4-IN THE LUNG RUN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "4-IN THE LUNG RUN" are provided by the European Opendata Portal: CORDIS opendata.